Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A bird's-eye view for future ionic thermoelectrics: from ions to products.

National science review·2026
Same author

Comparison of systolic and diastolic CT-FFR for myocardial ischemia diagnosis.

BMC medical imaging·2026
Same author

Combined carcinoembryonic antigen, carbohydrate antigen 50, and neutrophil gelatinase-associated lipocalin distinguish benign and malignant pleural effusions: a Bayesian analysis.

Scientific reports·2026
Same author

A Classifier Model Based on CT Data from Different CT Phases for Distinguishing LPAs and PCCs.

Archivos espanoles de urologia·2026
Same author

Correction: System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.

Journal of translational medicine·2026
Same author

An intelligent fusion model for Ki-67 prediction in non-small cell lung cancer: A cloud-based prediction system integrating radiomics.

European journal of radiology·2026

Related Experiment Video

Updated: Jul 3, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K

PMDAGS: Predicting miRNA-Disease Associations With Graph Nonlinear Diffusion Convolution Network and Similarities.

Cheng Yan, Guihua Duan

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |February 15, 2024
    PubMed
    Summary

    A new computational method, PMDAGS, effectively predicts microRNA-disease associations using graph nonlinear diffusion convolution networks. This approach enhances disease diagnosis and prognosis by identifying potential biomarkers.

    More Related Videos

    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
    03:37

    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

    Published on: March 1, 2024

    720
    CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
    10:40

    CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

    Published on: April 25, 2022

    2.4K

    Related Experiment Videos

    Last Updated: Jul 3, 2025

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
    07:35

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

    Published on: October 13, 2023

    1.6K
    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
    03:37

    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

    Published on: March 1, 2024

    720
    CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
    10:40

    CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

    Published on: April 25, 2022

    2.4K

    Area of Science:

    • Biomedical Informatics
    • Computational Biology
    • Genomics

    Background:

    • MicroRNAs (miRNAs) are crucial regulators of biological processes and serve as potential noninvasive biomarkers for disease diagnosis and prognosis.
    • Computational methods are vital for identifying miRNA-disease associations to improve disease management.

    Purpose of the Study:

    • To introduce PMDAGS, a novel computational method for predicting miRNA-disease associations.
    • To leverage graph nonlinear diffusion convolution networks and similarity measures for enhanced prediction accuracy.

    Main Methods:

    • Calculated miRNA and disease similarity using miRNA-target interactions, gene-disease associations, and known miRNA-disease associations.
    • Constructed initial node features by combining similarity vectors with known association vectors.
    • Applied a nonlinear diffusion graph convolution network to extract feature embeddings, followed by a multi-layer perceptron for association prediction.

    Main Results:

    • PMDAGS achieved high Area Under the Curve (AUC) values, including 0.9222 (5-fold cross-validation) on HMDD v2.0 and 0.9366 (5-fold cross-validation) on HMDD v3.2.
    • The method demonstrated superior performance compared to existing computational approaches in predicting miRNA-disease associations.
    • Cross-validation results (5CV, 10CV, GLOOCV) consistently validated the effectiveness of PMDAGS on both HMDD v2.0 and HMDD v3.2 datasets.

    Conclusions:

    • PMDAGS effectively predicts potential miRNA-disease associations.
    • The proposed method offers a significant advancement in computational approaches for biomarker discovery and disease association studies.
    • PMDAGS outperforms existing methods, highlighting its potential for clinical applications in disease diagnosis and prognosis.